Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sagimet Biosciences (SGMT) EBT Margin (2023)

Sagimet Biosciences has reported EBT Margin over the past 1 years, most recently at 317.85% for Q3 2023.

  • Quarterly results put EBT Margin at 317.85% for Q3 2023, changed N/A from a year ago — trailing twelve months through Jun 2024 was 1462.8% (changed N/A YoY), and the annual figure for FY2023 was 1394.0%, changed.
  • EBT Margin for Q3 2023 was 317.85% at Sagimet Biosciences.
  • Over the last five years, EBT Margin for SGMT hit a ceiling of 317.85% in Q3 2023 and a floor of 317.85% in Q3 2023.